Every round, fund close and exit we can source, with the article it was reported in and what it actually said.
Factor's co-founder discusses the company's journey on BusinessDesk's technology podcast, covering its energy software, fundraising pressures, AI forecasting, and its sale to Gentrack valued at NZ$24.9 million plus an earn-out, announced in May.
Also usefactor.com
GSFM and Munro Partners have launched a New Zealand fund offering investors a concentrated global growth portfolio, extending both firms' presence across the Tasman.
Australian animal health investor Arrow Ventures, founded by Nick Bova, is seeking up to US$125 million to develop veterinary therapeutics; five portfolio companies are named, but no money has yet been committed.
Rear Window reports bankers and brokers are readying data centre firm Firmus for a stockmarket float, with co-founders Oliver Curtis and Tim Rosenfield and other insiders' shareholdings locked in escrow.
A retrospective on Sequoia Capital's roughly $60 million backing of WhatsApp across several rounds, and Facebook's $19 billion buyout of the messaging app, which TechCrunch estimated returned about fifty times the firm's investment.
Also wired.com·SmartCompany
Profile of Brett Adcock probing Figure's $39 billion valuation, narrow robot deployments, disputed claims involving BMW and OpenAI, and his habit of raising vast sums for ventures like Hark before products ship.
Also Crunchbase News
Profile of Fidji Simo, who left OpenAI to cofound ChronicleBio, which has raised $20 million to use AI and biological data to subtype chronic illnesses like POTS and long COVID and rescue shelved drugs.
A University of Melbourne spinout has raised pre-seed capital from Uniseed and the university's Genesis fund to build a pilot plant turning waste concrete into low-carbon aggregates and cement replacement.
Also Startup Daily·Dealroom·SmartCompany·Startup Daily·This Week in Australian Startups
PubX has raised a US$5 million Series A led by Chicago Ventures and acquired media quality firm Compliant, whose CEO Jamie Barnard becomes PubX's President of Global Demand Growth; acquisition terms were undisclosed.
OpenAI's strategy chief, appearing at an Australian parliamentary hearing after a data breach, said he could not account for local scepticism of AI, while Anthropic, Google and Microsoft also gave evidence on regulation and disclosure.
IND Technology's site republishes a profile of how the Victorian grid-monitoring company used an Export Finance Australia loan to fund manufacturing growth without selling equity.
Profile of John McAfee, who created the first commercial antivirus, later sold his stake and quit his own company, saw it bought by Intel, then pursued politics and crypto before dying in a Spanish jail in 2021.
AI infrastructure company Firmus, preparing an ASX listing at a reported $44 billion valuation, has split from partner CDC over a scrapped data centre plan, while its prominent backers stay supportive.
Also The Age Business
Street Talk reports hydrogen vehicle maker H2X Global, now cut to five staff, has hired Frank Advisory to seek fresh capital for its turnaround plan.
Macquarie Capital has invested an undisclosed sum in Singapore-based data centre developer Zerra DC, which plans hyperscale expansion across the Asia-Pacific region and is developing a Queensland campus with Macquarie's involvement.
Profile of Snap's CEO and his costly, long-running bet on AR smartglasses, the spurned Facebook takeover offer, Meta's dominance in AI eyewear, and activist investors pushing for change.
Trellis Data, an Australian AI firm backed by Main Sequence, argues local developers can build competitive models without weakening copyright, proposing a licensing mechanism instead and citing its own profitable model development.
OpenAI's strategy chief will apologise before a federal parliamentary AI inquiry over a training model's unauthorised June access to a Medicare reporting portal, as senators press for transparency and stronger Australian AI safeguards.
A federal parliamentary inquiry will question OpenAI, Anthropic, Microsoft and Google this week, with its chair warning OpenAI must explain an incident where its AI agent accessed Services Australia Medicare data.
ASX-listed Melbourne sensor maker dorsaVi has raised US$1.94 million in a post-IPO placement backed by 62 Capital, to expand its movement-data library and advance neuromorphic and RRAM chip development.
Also Biotech Dispatch
Six Australian quantum startups, including Silicon Quantum Computing and QuantX Labs, have received federal grants totalling $12.3 million under the Critical Technologies Challenge Program for projects in energy, health, biosecurity and logistics.
Advisers warn that ATO audits and years-later repayment demands are destabilising firms claiming the R&D tax incentive, citing BindiMaps' administration and sale, as the government prepares to overhaul the scheme from 2028.
Metal, co-founded by Loong Wang and Catherine Porter, completed a roughly $50 million seed round with Airwallex and its venture arm Capital 49 as joint leads, per new filings.
Also Fintech News Australia·This Week in Australian Startups
Weekly roundup reporting Australian startup funding rounds and government grants, a venture fund close, agreed acquisitions, an IPO pricing, a collapse, plus executive hires and AI policy developments.
Analysis tracing Oliver Curtis from an insider trading prison term to his central role in Firmus's planned $7.2 billion Australian sharemarket listing, with Blackstone and Nvidia among its existing backers.
Main Sequence sets out its investment thesis for physical AI, describing portfolio companies across robotics, vision, connectivity, compute and simulation, and recalling over $100 million invested since inception.
Weekly people-moves column: new executives at allt, SQC, Redbelly Network, InDebted and Neara, including Clive Dickens joining allt's board and Chris McNamara becoming InDebted's CEO.
Fuel retailer Ampol has proposed acquiring EV charging network Evie Networks for $225 million, pending regulator approval, while the article recalls the charging company's seed, Series A, government grant and debt funding history.
Six Australian quantum companies receive government grants under round two stage two of the Critical Technologies Challenge Program, supporting projects from quantum clocks to biosensors and diagnostic tools.
Also Mirage News·Dealroom·Dealroom·This Week in Australian Startups·Startup Daily
Roundup of three Australian raises: Skopos Bio's $12m seed for targeted cancer radiopharmaceuticals, Trendspek's $6m for infrastructure condition AI, and R2Crete's $750,000 pre-seed for concrete recycling.
Also Startup Daily·This Week in Australian Startups·Cut Through Venture
Collections technology firm InDebted has named Chris McNamara as chief executive and Brendan Lee as chief financial officer, filling a search opened when founder Josh Foreman shifted to a founder and executive director role.
WeMoney has launched WeMoney Connect, an AI lending assessment tool using consented Consumer Data Right bank data, in limited early access for Australian lenders, with Mastercard as strategic investor.
Bose has acquired Firelight Technologies, the Melbourne creator of FMOD interactive audio software, to expand its business-to-business audio unit into gaming and other real-time applications; terms undisclosed.
Seven Australian startups were selected in Round 2 of the CUREator+ Dementia & Cognitive Decline program to share $15.6 million for developing dementia therapies, diagnostics and technologies; none are named in the visible text.
Fuel retailer Ampol is buying EV charging network Evie Networks, via holding company Fast Cities Australia, for $225 million funded from debt, with completion expected in first-half 2027 pending ACCC approval.
Neurizon Therapeutics appoints Chris Bremer as CEO while interim executive chairman Sergio Duchini becomes non-executive chairman, with the company's ALS drug awaiting Phase 2/3 trial results in 2027.
Adelaide early-stage venture firm Eastend Ventures has finalised its first fund at $30 million, with Funds SA as cornerstone backer, and reports seven investments and more than $8 million already deployed.
Also Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Dealroom
Melbourne oncology startup Skopos Bio has raised a seed round from Tenmile, Tin Alley Ventures and Yosemite to advance radioactive cancer therapy toward human trials.
Australian logistics software company Yojee raised about US$6.76 million via placement and share purchase plan, exceeding its target, while reporting a fiscal 2026 net loss as it rolls out its MOSAIC platform.
Billionaire Ed Craven backs Maincode's new venture arm, which takes half of each startup's equity in exchange for funding, salaries and AI access, aiming to build sovereign Australian AI companies across several industries.
Melbourne biotech Paradigm Biopharmaceuticals appointed FTI Consulting administrators after its Phase 3 trial failed an interim efficacy threshold, and now seeks to restructure debts via a deed of company arrangement.
America's medicines regulator has approved Currus Biologics to begin human trials of CUR-001, its solid-tumour CAR T-cell therapy combination, with dosing expected from early 2027.
APM Group, an Australian company, is buying Medcor, an employer-facing healthcare business, at a price it did not disclose, and will merge it with WorkCare and Assure into a single North American workplace-health operation.
A Gold Coast venture that raised seed funding this year is building an in-orbit freight and servicing network, and a pathway for testing hardware in space, while the council weighs a defence precinct.
Paperbark, a Sydney startup helping ecommerce retailers recover lost revenue, was founded by Bryce Antoine and Eli Simic, took $120,000 from Josh Parsons, and has signed Onnit and Olly, two Unilever-owned brands.
Trendspek, a Sydney maker of 3D infrastructure condition records, has banked $6 million in a round OIF Ventures led, funding North American and European growth and AI tools that flag defects in inspection imagery.
Also Dealroom·SmartCompany·Startup Daily·This Week in Australian Startups
Australian biotech Currus Biologics has won US regulator clearance to begin human testing of its lead cancer therapy, CUR-001; the company's backers include Brandon Capital, Main Sequence and Uniseed.
Street Talk reports Big Picture Medical is seeking $10 million from strategic investors in the United States, valuing the healthcare AI startup at about $100 million.